CD4 and neoplasm: Compared to the 2 mg/kg protein treatment group, 8 mg/kg shTRAIL treatment not only significantly increased CD4+ T cells, Tregs, and M2 macrophages in the tumor but also upregulated IL-10 expression in intratumoral M2 macrophages (Fig. 7E).